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Summary We have compared the levels of creatine kinase (CK) activity and the distribution of CK isoenzymes determined by agarose gel
electrophoresis in normal colon, liver and lung tissues, and in colon, liver and lung adenocarcinomas, lung squamous cell carcinomas and
lung carcinoids. Colon and lung adenocarcinomas, and squamous cell carcinomas presented lower CK activity than the normal tissues and
no differences were found between hepatocarcinoma and normal liver tissue. In contrast, lung carcinoids had higher CK activity than normal
lung tissue. Type BB-CK was the predominant isoenzyme in normal lung, colon and livertissues. Type MM isoenzyme was detected in normal
lung and type MB-CK was found in normal colon. In most lung tumours the CK isoenzyme electrophoretic pattern did not change. However,
no type BB-CK was detected in some hepatocarcinomas, type MM-CK decreased in lung carcinoids and type MB isoenzyme was not
observed in colon adenocarcinomas. It is concluded that in most tumours there is a decrease in the expression of type B- and type M-CK
subunits, whereas in lung carcinoid the expression of type B-CK activity increases. Thus, the increase in type BB-CK observed in the serum
of patients with lung and colon adenocarcinomas is probably due mainly to enhanced enzyme release as a result of tumour cell necrosis.
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Creatine kinase (ATP:creatine N-phosphotransferase, EC 2.7.3.2,
CK) is a ubiquitous enzyme that catalyses the reversible trans-
phosphorylation reaction between ATP and creatine, generating
ADP and phosphocreatine (for a review see Bessman and
Carpenter, 1985). In mammalian tissues four CK subunits are
expressed, encoded by different genes: two cytosolic subunits (M-
CK and B-CK) and two mitochondrial (Mt-CK) subunits, 'ubiqui-
tous' Mt-CK (uMt-CK) and 'sarcomeric' Mt-CK (sMt-CK). In
vivo, M-CK and B-CK subunits combine to give three dimeric
cytosolic CK isoenzymes: type MM-, MB-, and BB-CK. MM-CK
is rather specific for differentiated striated muscle (Burger et al.,
1963) and mature spermatozoa (Huszar and Vigue, 1990). BB-CK
is found in most adult tissues as well as in embryonic skeletal and
cardiac muscle. MB-CK is detected in adult mammalian heart and
in straited muscle during the developmental transition. The Mt-CK
subunit forms octameric and dimeric molecules located within the
mitochondrial intermembrane space (for review see Foreback and
Chu, 1981; Wallimann et al, 1992; Wyss et al, 1992).
The present study was undertaken to determine the distribution
of the total CK activity and isoenzymes in lung, colon and liver
carcinomas as a first step to study the alterations ofthe expression
of creatine kinase isoenzymes in neoplastic cells. Many reports
have been published on the distribution of CK subunits and iso-
enzymes in tumours (for review see Foreback and Chu, 1981; Bais
and Edwards, 1982; Griffiths, 1982; Nanji, 1983; Kanemitsu and
Okigaki, 1988). However, most data have been obtained by
immunohistochemical and immunoassay techniques.
MATERIALS AND METHODS
Materials
Enzymes, substrates, co-factors and biochemicals were purchased
from either Boehringer (Mannheim, Germany) or Sigma (StLouis,
MI, USA). CK-MB DS reaction mixture (cat. no. 1.12948) from
Merck (Darmstadt, Germany) was used as source of M-CK anti-
bodies. P-Mercaptoethanol was from Merck and bovine serum
albumin was from Calbiochem (La Jolla, CA, USA). Other chem-
icals were reagent grade. Agar noble was obtained from Difco
Laboratories (Detroit, MI, USA) and agarose gels were from Ciba-
Coming (Palo Alto, CA, USA).
Tissue samples
Tumour samples were obtained from surgical resection specimens:
seven lung adenocarcinomas, five lung squamous cell carcinomas,
two carcinoid tumours ofthe lung, ten colon adenocarcinomas and
six hepatocarcinomas. Samples of normal tissue were obtained
from adjacent normal tissue that had to be removed during tumour
surgery.
Tissue extraction
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Tissue extracts were prepared by homogenization in three volumes
(w/v) of cold Tris-buffer (20 mm Tris, 1 mM EDTA, 1 mM 3-
mercaptoethanol, pH 7.5) with a Polytron homogenizer (Lucerne,
Switzerland) (position 5, 20 s). Cellular debris were removed by
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Table 1 Creatine kinase activity in human lung, colon, and liver normal tissues and tumours
Normal tissue Tumour
Tissue Tumour Case no. U g-la U mgnb U g-1' U mg-lb
Lung Adenocarcinoma
Squamous cell carcinoma
Carcinoid
Colon Adenocarcinoma
Liver Hepatocarcinoma
2
3
4
5
6
Mean ± s.e.m.
Median (range)
2.2
6.6
7.3
5.2
4.0
4.7
5.0 ± 0.75
4.9 (2.2-7.3)
0.18
0.10
0.10
0.11
0.10
0.07
0.11 ± 0.01
0.10 (0.07-0.18)
1.9
8.0
4.6
4.2
4.1
3.9
4.46 ± 0.8
4.15(1.9-8.0)
0.13
0.14
0.13
0.11
0.17
0.13
0.13 ± 0.008
0.13 (0.11-0.17)
The activity is expressed as units of activity per g of wet tissue and as units per mg of extracted protein. The contrasts are as follows: alung (median and range:
15.7, 6.9-25) vs colon, P< 0.0001; lung (median and range: 15.7, 6.9-25) vs liver, P < 0.001; colon vs liver, P< 0.001; blung (median and range: 0.3, 0.2-0.6)
vs colon, P< 0.0001; lung (median and range: 0.3, 0.2-0.6) vs liver, P< 0.0001; colon vs liver, P < 0.001.
centrifugation (12 500 g, 30 min, 4°C) and the supernatants were
used for the assay ofCK activity and isoenzymes.
Enzyme assays
CK activity was measured spectrophotometrically at 30°C essen-
tially as recommended by the International Federation of Clinical
Chemistry (H0rder et al., 1991). The assay is based on the forma-
tion of ATP linked to the production of NADPH via hexokinase
and glucose-6-phosphate dehydrogenase. The reaction mixture
contained 100 mm imidazole acetate, 2 mm EDTA, 10 mM magne-
sium acetate, 2 mm ADP, 5 mm AMP, 20 mM N-acetylcysteine,
20 mM D-glucose, 2 mv NADP, 30 mm phosphocreatine, hexo-
kinase (3 U ml-'), glucose-6-phosphate dehydrogenase (2 U ml-'),
pH 6.7. Enzyme activities were expressed as U g-1 wet tissue and
as Umg-' protein (1 unit = 1 jmol ofsubstrate converted permin).
Protein was determined by the method of Bradford (1976) using
bovine serum albumin as a standard.
Isoenzyme analysis
CK isoenzymes were separated by electrophoresis in agarose gels
(Coming, cat. no 470104). Electrophoresis was performed at 40C
in Tris-sodium barbital buffer, pH 8.8 (Electra HR Buffer, cat. no.
5805), for 60 min at 95 V. CK isoenzymes were stained using a
mixture containing 50 mM Tris, 90 im phosphocreatine, 12 mM
ADP, 60 mm magnesium chloride, 6 mM NAD, 60 mM glucose,
60 mM N-acetylcysteine, 15 mm AMP, 0.2 mm adenosine penta-
phosphate, hexokinase (9 U ml-'), glucose-6-phosphate dehydro-
genase (7.5 U ml-'), pH 6.7. After electrophoresis was completed,
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2
3
4
5
6
7
2
3
4
5
2
Mean ± s.e.m.
Median (range)
Mean ± s.e.m.
Median (range)
Mean ± s.e.m.
Median (range)
16
24
19
6.9
8.3
13.8
9.5
13.9 ± 2.3
13.8 (6.9-24)
23
25
16
12.8
9.6
17.3 ± 2.9
16 (9.6-25)
21
15.5
18.2 ± 2.7
18.2 (15.5-21)
73
136
93
95
132
179
88
23
68
147
103.4 ± 14.3
94 (23-179)
0.3
0.4
0.6
0.26
0.2
0.28
0.26
0.33 ± 0.05
0.28 (0.2-0.6)
0.3
0.3
0.3
0.2
0.4
0.3 ± 0.03
0.3 (0.2-0.4)
0.4
0.5
0.45 ± 0.05
0.45 (0.4-0.5)
1.4
3.0
1.8
1.7
4.9
4.9
1.3
1.3
1.3
2.6
2.4 ± 0.45
1.75 (1.3-4.9)
3.6
10
12
4.6
2.9
11.1
4.8
7.0 ± 1.5
4.8 (2.9-12.0)
12
4.1
9.4
2.6
3.4
6.3 ± 1.8
4.1 (2.6-12.0)
151
201
176 ± 25
176 (151-201)
14
49
47
44
3
25
113
38
72
74
47.9 ± 10.2
45.5 (3-113)
0.07
0.1
0.3
0.15
0.08
0.28
0.1
0.15 ± 0.04
0.1 (0.07-0.30)
0.1
0.1
0.2
0.05
0.16
0.12 ± 0.03
0.1 (0.05-0.2)
2.6
9.5
6.05 ± 3.45
6.05 (2.6-9.5)
0.3
0.9
0.8
0.7
0.07
0.35
2.3
1.05
1.4
1.4
0.92 ± 0.2
0.85 (0.07-2.3)
2
3
4
5
6
7
8
9
10
Mean ± s.e.m.
Median (range)
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Figure 1 Electrophoretograms of CK isoenzymes in extracts of lung normal tissue and tumours. Lane 1, human heart extract; lanes 2, 6 and 12,
adenocarcinomas; lanes 4, 8 and 10, squamous cell carcinomas; lanes 14 and 16, carcinoids; lanes 3, 5, 7, 9, 11, 13, 15 and 17, corresponding normal tissues
the agarose gel plate was covered with 16 ml of staining mixture
(freshly prepared) containing 1% (w/v) agar gel, and incubated at
37°C for 20 min in the dark. The gels were air-dried and
photographed with aPolaroid MP4 Land Camera. The photograph
was scanned at 500 nm with a Shimadzu CS-9000 densitometer.
Linearity in the quantitation ofbands was determined by applying
different aliquots containing increasing amounts of CK. The
method was found to be linear (correlation coefficient of0.99) up
to 8.5 mU ofCK, with a lower detection limit of0.6 mU ofCK.
Inhibition of CK-M subunit
Aliquots of lung (10 ,ul) and colon (25 gl) extracts containing 8
and 45 U ml respectively were mixed with 40 gl and 25 ,ul
respectively of the solution containing CK-M antibodies. After
3 min ofincubation at 30°C, the mixture was cooled in an ice bath,
and the CK isoenzymes were determined as described above.
Statistical analysis
Repeated measures were employed for statistical evaluation, and
to compare CK activity in tumour and control tissues the Wilcoxon
t-test was used. In order to compare CK activity levels among
different tissues, the Kruskal-Wallis test was employed. The
difference between groups was identified with the Mann-Whitney
U-test. All P-values are two-tailed. Values are reported as
mean ± s.e.m. and as median and range. Data were analysed by
INSTAT statistical software.
RESULTS
Distribution of CK activity in lung, colon and liver
normal tissues and tumours
Table I summarizes the levels oftotal CK activity in normal lung,
colon and liver tissues, and in their tumours. As shown, colon is
the tissue with highest CK content. When expressed as U mg' of
protein, the CK activity ofcolon extracts is about sevenfold that of
lung extracts and about 20-fold that ofliver extracts.
Extracts of colon and lung adenocarcinomas possess lower CK
activity than the corresponding normal tissues (P < 0.05). Lung
squamous cell carcinomas tend also to have lowerCKactivity than
normal lung tissue, although the differences observed are not
statistically significant. In contrast, the extracts of two carcinoids
ofthe lung possess much higher CK levels than the extracts ofthe
corresponding normal tissue. No differences have been found
between hepatocarcinomas and normal liver tissue.
Distribution of CK isoenzymes in lung normal tissue
and tumours
Figure 1 shows some of the electrophoretograms of lung tumours
and ofthe corresponding normal tissues determinedby agarose gel
electrophoresis.
In all 14 normal specimens studied by us, one anodic band was
detected, corresponding to type BB-CK, and one or two very thin
cathodic bands that migrate in a similar manner to the dimeric and
octameric forms ofMt-CK (lanes 7, 9, 11 and 13) was defected. In
four samples we observed an additional band in a position equiva-
lent to that oftype MM-CK (lanes 3 and 5), but type MB-CK was
not detected in any specimens.
In a control experiment (not shown), no band was visualized
when phosphocreatine was omitted from the staining mixture,
which proved that the bands were not adenylate kinase. As shown
in Figure 2, the band migrating as type MM-CK was not detected
after incubation of lung extract with anti-M-CK antibodies. In
contrast, the cathodic bands migrating as Mt-CK were not affected
by this treatment. Thus, we conclude that BB-CK is the main CK-
cytosolic isoenzyme present in normal human lung tissue,
although MM-CK can be also detected.
We found that the CK isoenzyme electrophoretic pattems of
extracts of adenocarcinomas (Figure 1, lanes 2, 6, and 12) and of
squamous cell carcinomas ofthe lung (Figure 1, lanes 4, 8 and 10)
did not present qualitative differences compared with extracts of
the corresponding normal tissues. In contrast, in two carcinoids of
the lung, we observed a change in the normal CK electrophoretic
pattem. Only the band oftype BB-CK was detected in the extracts
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of the carcinoids (Figure 1, lanes 14 and 16), whereas an addi-
tional cathodic band migrating as Mt-CK was observed in the
corresponding normal tissues.
Distribution of CK isoenzymes in colon normal tissue
and tumours
In all extracts of normal colon (Figure 3, lanes 3, 5 and 7), we
observed the presence of BB-CK and of two cathodic bands
migrating as the dimeric and octameric forms ofMt-CK. In addi-
tion, an anodic band in aposition corresponding to that ofMB-CK
was observed in three out of ten specimens (lanes 3 and 5). As
shown in Figure 2 (lane 6), the band migrating as MB-CK was
undetectable after incubation of the extract with anti-M-CK anti-
bodies, whereas the two cathodic bands were not affected by this
treatment. BB-CK was predominant in all specimens. The propor-
tion of Mt-CK with respect to the total CK activity could not be
quantified from the electrophoretograms, as in order to detect the
Mt-CK bands it was necessary to apply large volumes of the
extracts, over the limit ofproportionality ofthe staining method.
As in the normal tissue, in colon adenocarcinomas (Figure 3
lanes 2, 4 and 6) BB-CK was the predominant CK isoenzyme.
However, the band ofMB-CK detected in some normal specimens
was not present in tumoral tissue, which shows a decrease in the
expression oftype M-CK subunit.
0
2
Figure 2 Effect of M-CK antibodies on the CK electrophoretic bands
detected in extracts of human skeletal muscle, lung and colon. Lanes 1, 3
and 5, muscle, lung and colon extracts; lanes 2, 4 and 6, muscle, lung and
colon extracts treated with M-CK antibodies
Distribution of CK isoenzymes in liver normal tissue
and tumours
As shown in Figure 3 (lanes 11, 13 and 15), we detected in six
extracts ofnormal liverthe bandcorresponding to BB-CK and two
cathodic bands corresponding to Mt-CK. In addition, we detected
a faint band slightly ahead ofMM-CK, which in a control experi-
ment (not shown) was proved to correspond to adenylate kinase
not inhibited by the AMP present in the staining mixture. It is
known that liver adenylate kinase is more resistant to inhibition
A
BB
MB
MM
Mt
than the other adenylate kinase isoenzymes (Hamada et al, 1987;
Schulz et al, 1987). No MM-CK was detected in any specimen.
Most of the extracts of hepatocarcinomas analysed by us
showed the same CKelectrophoretic pattern as that ofnormal liver
tissue. However, BB-CK was not detected in two of them (Figure
3, lane 14).
B
1 2 3 4 5 6 7 8 9 10 1 1 12 13 14 19 lf1
Figure 3 Electrophoretograms of CK isoenzymes in extracts of human liver and colon normal tissues and tumours. Colon specimens are shown in A: lanes 2, 4
and 6, adenocarcinomas; lanes 3, 5 and 7, normal tissues. Liver specimens are shown in B: lanes 10, 12 and 14, hepatocarcinomas; lanes 11, 13 and 15,
normal tissues. Lanes 1 and 9, human heart extracts. Lanes 8 and 16, human brain extracts (cortex)
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DISCUSSION
Ourdata show that colon and lung adenocarcinomas and squamous
cell carcinomas of the lung possess lower CK activity than the
corresponding normal tissues. In contrast, lung carcinoids have
higher CK levels and no difference exists between CK levels in
hepatocarcinomas and in normal liver tissue. These results agree
with other published results on colon carcinomas (Tsung, 1982b,
1983) and lung carcinomas (Coolen et al, 1979; Gazdar et al, 1981;
Tsung, 1983). Most data obtained by immunological techniques
(Wretou and Pfleiderer, 1975; Usui et al, 1987), ion-exchange
chromatography (Roberts et al, 1975; Tsung 1976, 1983; Vergnon,
1983) and electrophoresis (Allard and Cabrol, 1970; Smith, 1972;
Coolen et al, 1979) have shown that in normal lung BB-CK is the
predominant isoenzyme. MM-CK is found in a much lower
proportion and MB-CK is present at very low levels. Only one
report (Roberts et al, 1975) detected higher levels ofMM-CK than
of BB-CK. Our results confirm that BB-CK is the major CK
cytosolic isoenzyme in normal lung tissue, although MM-CK is
also present at much lower levels. The absence of MB-CK in
extracts that possess MM- and BB-CK suggests that type M- and
type B-CK subunits are expressed in different lung cell types.
Using immunological techniques, some authors (Wold et al,
1981; Gosney et al, 1994) found lower expression of BB-CK in
small-cell lung carcinomas than in other lung carcinomas.
However, other authors (Gazdar et al, 1981; Carney et al, 1984;
Usui et al, 1987) have reported that the levels ofBB-CK in small-
cell lung carcinomas are much greater than those of normal lung,
and that the BB-CK levels in non-small-cell lung carcinomas are
lower than those of normal lung (Gazdar et al, 1981; Usui et al,
1987). In all types oflung carcinoma (except one case ofsmall-cell
carcinoma), MB-CK and MM-CK levels were found by Usui et al
(1987) to be low and similar to those of normal lung. Using ion-
exchange chromatography (Tsung, 1983) and by electrophoretic
analysis (Coolen et al, 1979; De Luca et al, 1981; Gazdar et al,
1981; Tsung, 1983; Lee et al, 1985; McGing et al, 1988), it has
also been found that BB-CK is the predominant CK isoenzyme in
several types of lung carcinoma. Our results show that, whereas
lung adenocarcinomas and squamous cell carcinomas possess BB-
and MM-CK isoenzymes in a proportion similar to those of the
normal lung tissue, the proportion of BB-CK increases in carci-
noids ofthe lung.
It has been shown by electrophoresis (Griffiths, 1982; Tsung,
1982a, 1982b, 1983; Urdal et al, 1983; Chastain et al, 1988), ion-
exchange chromatography (Tsung, 1976, 1982a, 1982b, 1983) and
immunoinhibition (Chastain et al, 1988) that human colon
possesses mainly type BB-CK. BB-CK has been found to be
predominant also in colon adenocarcinomas (Coolen et al, 1979;
Tsung 1982b, 1983). However, Graeber et al (1981) reported
significant amounts ofMM-CK and MB-CK in normal colon, and
Tsung (1982b, 1983) indicated that colon malignant tissue had a
higher proportion of MM-CK than normal tissue. The conflicting
results can be explained by the confusion created by Mt-CK and
BB-CK. Mt-CK, which is more abundant in colon tumours than in
normal colon tissue (Okano et al, 1987; McGing et al, 1988), can
contaminate the MM-CK band. Post-mortem changes in BB-CK
can produce a band with an electrophoretic mobility similar to that
ofMB-CK (Chastain et al, 1988). Our results show that BB-CK is
the major CK isoenzyme in normal colon tissue and in colon
adenocarcinoma, and that MB-CK, which is found in low propor-
tion in normal tissue, is not detectable in colon tumours.
The distribution of CK isoenzymes in human liver has been
determined by immunotitration (Wretou and Pfleiderer, 1975),
ion-exchange chromatography (Roberts et al, 1975; Wretou and
Pfleiderer, 1975; Tsung, 1976, 1983) and electrophoresis (Allard
and Cabrol, 1970; Smith, 1972; Griffiths, 1982; Tsung, 1983).
Some studies have reported only type BB-CK, but others have
detected predominantly MM-CK. In two human liver tumours
carried in athymic mice, DeLuca et al (1981) showed a high
proportion ofBB-CK and a low concentration ofMM-CK and Mt-
CK. The discrepancies probably result from confusion created by
Mt-CK. Liver mitochondrial extracts have two cathodic Mt-CK
forms that can be converted into a new form at the MM-CK posi-
tion after long-term storage (Kanemitsu, 1982a, 1982b, 1983).
Moreover, liver Mt-CK is readily released (Urdal et al, 1983). Our
results confirm that BB-CK is the predominant CK isoenzyme in
both normal liver tissue and hepatocarcinoma, although two ofsix
tumours presented a large decrease in BB-CK levels.
In summary, the results herein presented demonstrate that, in
contrast to phosphoglycerate mutase and enolase activities
(Durany et al, 1997), CK activity does not increase in most lung,
colon and liver carcinomas. One exception is the carcinoid of the
lung which, as has been reported to occur in small-cell lung carci-
noma, presents higher CK activity than the normal tissue. The
results also show that in most tumours there is a decrease in the
expression oftype M-CK subunit that is present at very low levels
in normal lung, and colon tissues.
Normal human serum contains MM-CK almost exclusively and
it has been suggested that serum BB-CK could be used as a tumour
marker (Foreback and Chu, 1981; Bais and Edwards, 1982;
Grifflths, 1982; Nanji, 1983; Kanemitsu and Okigaki, 1988).
Serum BB-CK increases in patients with small-cell lung carci-
noma, which has higher BB-CK levels than the normal lung tissue.
But serum BB-CK has also been found increased in patients with
squamous cell carcinoma and adenocarcinoma of the lung and in
patients with late-stage colon adenocarcinoma (Hoag et al, 1978;
Coolen et al, 1979; Bumam et al, 1981; Griffiths, 1982; Mercer
and Talamo, 1985; Usui et al, 1987; Arenas et al, 1989). As these
tumours have lower BB-CK levels than the normal tissues, we
conclude that the increase observed in serum BB-CK levels is
probably mainly due to enhanced enzyme release from tumour cell
necrosis.
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